Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Antibacterial amide derivatives of amythiamicin claimed by Japanese institute

April 29, 1998

Ionotropic glutamate receptor ligands for neurological and CNS disorders

April 28, 1998

Takeda reveals novel inhibitors of Na+/H+ exchange

April 28, 1998

Substance P antagonists from Pfizer especially useful for pain, inflammation

April 28, 1998

Anti-MRSA carbapenems developed at Suntory

April 28, 1998

Lilly presents naphthalene and related compounds for postmenopausal therapy

April 28, 1998

Toagosei presents several related antitumor series

April 28, 1998

Gastric prokinetic/antiemetic agents from Dainippon

April 28, 1998

Toyama focuses on cephalosporins, particularly anti-MRSA compounds

April 27, 1998

Cathepsin inhibitors under study at Nippon Chemiphar

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.